Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

165.00
USD
-9.00
(-5.17%)
19.78EPS
12.06P/E
33.03BMarket Cap
Feb 18Next Earn

Alnylam Pharmaceuticals, Inc. Documents

Q2 FY2021 · Quarterly report

August 3, 2021 · 75 pages

Read Alnylam Pharmaceuticals, Inc.'s results firsthand

Preview the first 2 pages of this quarterly report
Create a free account to start reading

Full documents are included with Professional

Q2 FY2021 documents